MEF2D and Parkinson disease: Interestingly, GSEA also indicated LCNM+-enriched expression of genes that are regulated by several TFs—ATF4, EBF3, STAT3, and MEF2D—all of which are protective against Parkinson’s disease, or associated with NM content in dopamine cells of the substantia nigra107–111.